MCID: INT038
MIFTS: 39

Interdigitating Dendritic Cell Sarcoma

Categories: Blood diseases, Cancer diseases

Aliases & Classifications for Interdigitating Dendritic Cell Sarcoma

MalaCards integrated aliases for Interdigitating Dendritic Cell Sarcoma:

Name: Interdigitating Dendritic Cell Sarcoma 12 15
Dendritic Cell Sarcoma, Interdigitating 44 73
Interdigitating Cell Sarcoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:7848
ICD10 33 C96.4
MeSH 44 D054739
NCIt 50 C9282
UMLS 73 C1260326

Summaries for Interdigitating Dendritic Cell Sarcoma

Disease Ontology : 12 A histiocytic and dendritic cell cancer that effect dendritic cells.

MalaCards based summary : Interdigitating Dendritic Cell Sarcoma, also known as dendritic cell sarcoma, interdigitating, is related to follicular dendritic cell sarcoma and reticulum cell sarcoma, and has symptoms including fever, fatigue and night sweats. An important gene associated with Interdigitating Dendritic Cell Sarcoma is CR2 (Complement C3d Receptor 2), and among its related pathways/superpathways are Hematopoietic Stem Cell Differentiation Pathways and Lineage-specific Markers and Complement Pathway. The drugs Cyclophosphamide and Gemcitabine have been mentioned in the context of this disorder. Affiliated tissues include bone, liver and b cells, and related phenotypes are Increased shRNA abundance (Z-score > 2) and Increased shRNA abundance (Z-score > 2)

Related Diseases for Interdigitating Dendritic Cell Sarcoma

Diseases related to Interdigitating Dendritic Cell Sarcoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 43)
# Related Disease Score Top Affiliating Genes
1 follicular dendritic cell sarcoma 32.6 CR1 CR2
2 reticulum cell sarcoma 32.0 CR1 CR2 PTPRC
3 histiocytosis 30.0 CD163 PTPRC
4 histiocytic sarcoma 29.7 CD163 CR1 CR2
5 sarcoma 11.0
6 lymphoma 10.4
7 melanoma 10.4
8 spindle cell sarcoma 10.4
9 liver inflammatory pseudotumor 10.1 CR2 PTPRC
10 hodgkin's lymphoma, lymphocytic-histiocytic predominance 10.1 CR2 PTPRC
11 ovarian lymphoma 10.1 CR2 PTPRC
12 leukemia, chronic lymphocytic 2 10.1
13 leukemia, chronic lymphocytic 10.1
14 langerhans cell histiocytosis 10.1
15 b-cell lymphomas 10.1
16 diffuse large b-cell lymphoma 10.1
17 leukemia 10.1
18 lymphocytic leukemia 10.1
19 leiomyosarcoma 10.1
20 malignant spindle cell melanoma 10.1
21 retroperitoneal leiomyosarcoma 10.1
22 cll/sll 10.1
23 pemphigus 10.1
24 acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) 10.1
25 leukemia, b-cell, chronic 10.1
26 paraneoplastic pemphigus 10.1
27 spleen cancer 10.0 CD163 CR2
28 rosai-dorfman disease 10.0 CD163 CR2
29 photokeratitis 10.0 CD163 PTPRC
30 leukocyte disease 10.0 CR2 PTPRC
31 reticulohistiocytic granuloma 10.0 CD163 PTPRC
32 parapharyngeal meningioma 10.0 CR1 CR2
33 lymphoblastic lymphoma 10.0
34 t-cell/histiocyte rich large b cell lymphoma 10.0 CR1 CR2
35 lateral medullary syndrome 9.9 CR1 CR2
36 histiocytoma 9.9 CD163 PTPRC
37 castleman disease 9.9 CR1 CR2
38 dendritic cell tumor 9.8 CR1 CR2 PTPRC
39 inflammatory myofibroblastic tumor 9.8 CR1 CR2
40 langerhans cell sarcoma 9.7 CD163 CR1 CR2
41 hemophagocytic lymphohistiocytosis 9.7 CR1 CR2
42 leukemia, acute myeloid 9.7 CR1 PTPRC SPI1
43 histiocytic and dendritic cell cancer 9.4 CD163 CR1 CR2 POLQ PTPRC

Graphical network of the top 20 diseases related to Interdigitating Dendritic Cell Sarcoma:



Diseases related to Interdigitating Dendritic Cell Sarcoma

Symptoms & Phenotypes for Interdigitating Dendritic Cell Sarcoma

UMLS symptoms related to Interdigitating Dendritic Cell Sarcoma:


fever, fatigue, night sweats

GenomeRNAi Phenotypes related to Interdigitating Dendritic Cell Sarcoma according to GeneCards Suite gene sharing:

26 (show all 22)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-100 9.72 SPI1
2 Increased shRNA abundance (Z-score > 2) GR00366-A-105 9.72 PTPRC
3 Increased shRNA abundance (Z-score > 2) GR00366-A-120 9.72 SPI1
4 Increased shRNA abundance (Z-score > 2) GR00366-A-121 9.72 PTPRC SPI1
5 Increased shRNA abundance (Z-score > 2) GR00366-A-122 9.72 SPI1
6 Increased shRNA abundance (Z-score > 2) GR00366-A-124 9.72 CD163
7 Increased shRNA abundance (Z-score > 2) GR00366-A-13 9.72 SPI1
8 Increased shRNA abundance (Z-score > 2) GR00366-A-137 9.72 CD163
9 Increased shRNA abundance (Z-score > 2) GR00366-A-147 9.72 SPI1
10 Increased shRNA abundance (Z-score > 2) GR00366-A-149 9.72 CD163 PTPRC SPI1
11 Increased shRNA abundance (Z-score > 2) GR00366-A-161 9.72 SPI1
12 Increased shRNA abundance (Z-score > 2) GR00366-A-177 9.72 CD163
13 Increased shRNA abundance (Z-score > 2) GR00366-A-2 9.72 PTPRC
14 Increased shRNA abundance (Z-score > 2) GR00366-A-214 9.72 PTPRC
15 Increased shRNA abundance (Z-score > 2) GR00366-A-41 9.72 PTPRC
16 Increased shRNA abundance (Z-score > 2) GR00366-A-47 9.72 SPI1
17 Increased shRNA abundance (Z-score > 2) GR00366-A-50 9.72 PTPRC
18 Increased shRNA abundance (Z-score > 2) GR00366-A-52 9.72 CD163
19 Increased shRNA abundance (Z-score > 2) GR00366-A-74 9.72 CD163
20 Increased shRNA abundance (Z-score > 2) GR00366-A-81 9.72 CD163
21 Increased shRNA abundance (Z-score > 2) GR00366-A-83 9.72 CD163
22 Increased shRNA abundance (Z-score > 2) GR00366-A-9 9.72 CD163

MGI Mouse Phenotypes related to Interdigitating Dendritic Cell Sarcoma:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.43 CD163 CR2 FNIP1 POLQ PTPRC SPI1
2 immune system MP:0005387 9.1 CD163 CR2 FNIP1 POLQ PTPRC SPI1

Drugs & Therapeutics for Interdigitating Dendritic Cell Sarcoma

Drugs for Interdigitating Dendritic Cell Sarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 501)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 6055-19-2, 50-18-0 2907
2
Gemcitabine Approved Phase 4,Phase 3,Phase 2,Phase 1 95058-81-4 60750
3
Vincristine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 57-22-7, 2068-78-2 5978
4
Etoposide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 33419-42-0 36462
5
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 50-02-2 5743
6
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 1177-87-3
7
Cisplatin Approved Phase 4,Phase 3,Phase 2,Phase 1 15663-27-1 2767 441203 84093
8
Ifosfamide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 3778-73-2 3690
9
Epirubicin Approved Phase 4,Phase 2 56420-45-2 41867
10
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 53-03-2 5865
11
Thiotepa Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 52-24-4 5453
12
Lenograstim Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 135968-09-1
13
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-24-8 5755
14
leucovorin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 58-05-9 6006 143
15
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83-43-2 6741
16
Vindesine Approved, Investigational Phase 4,Not Applicable 59917-39-4, 53643-48-4 40839
17
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 59-05-2, 1959-05-2 126941
18
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 302-25-0
19
Cytarabine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 147-94-4 6253
20
Methylprednisolone hemisuccinate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 2921-57-5
21
Doxorubicin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 23214-92-8 31703
22
rituximab Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 174722-31-7 10201696
23
Mechlorethamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 51-75-2 4033
24
Crizotinib Approved Phase 4,Phase 1,Phase 2 877399-52-5 11626560 10366136 10366137 10366138 10366139 10366140 10366141
25
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 59-30-3 6037
26
Doxil Approved June 1999 Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 31703
27
Prednisolone hemisuccinate Experimental Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 2920-86-7
28
Pirarubicin Investigational Phase 4 72496-41-4
29
Isophosphamide mustard Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 0
30 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
31 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
32 Antineoplastic Agents, Alkylating Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
33 Topoisomerase Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
34 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
35 Immunologic Factors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
36 Antineoplastic Agents, Hormonal Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
37 Antimitotic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
38 Alkylating Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
39 Hormones Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
40 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
41 Antineoplastic Agents, Phytogenic Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
42 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
43 BB 1101 Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
44 Etoposide phosphate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
45 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
46 Antirheumatic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
47 glucocorticoids Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
48 Antilymphocyte Serum Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
49 Antimetabolites Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
50 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1

Interventional clinical trials:

(show top 50) (show all 885)
# Name Status NCT ID Phase Drugs
1 CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL Unknown status NCT02533700 Phase 4 CEOP/IVE/GDP chemotherapy regimen;CEOP chemotherapy regimen for 6 cycles
2 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Completed NCT00003398 Phase 4 cyclophosphamide;thiotepa
3 Trial for the Treatment of Newly Diagnosed Mature B-Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt's Non-Hodgkin's Lymphoma (NHL) and Other High-grade Lymphoma in Adults Completed NCT00199082 Phase 4 Adriamycin;Cyclophosphamide;Cytarabine;Dexamethasone/Prednisolone;VP16;Ifosfamide;Methotrexate;G-CSF;Rituximab;Vincristine/Vindesine
4 Study of Brentuximab Vedotin in Patients With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma Recruiting NCT01909934 Phase 4 brentuximab vedotin
5 Crizotinib Combined With Etoposide Capsule Followed by Auto-HSCT for Relapsed and Refractory ALK+ ALCL Recruiting NCT03707847 Phase 4 Crizotinib;Etoposide Capsule
6 CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma Active, not recruiting NCT01746992 Phase 4 Cyclophosphamide 750mg/m2;Vincristine 1.4mg/m2;Doxorubicin 50mg/m2;prednisone 60mg/m2;ifosfamide 2000mg/m2;pirarubicin 50mg/m2;pirarubicin 25mg/m2;Etoposide phosphate 100mg/m2;methotrexate 1500mg/m2
7 A Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib Withdrawn NCT02487316 Phase 4 crizotinib
8 Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma Unknown status NCT00006455 Phase 3 cyclophosphamide;cytarabine;dexamethasone;doxorubicin hydrochloride;etoposide;ifosfamide;leucovorin calcium;methotrexate;therapeutic hydrocortisone;vinblastine sulfate
9 Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia Unknown status NCT00445497 Phase 3 amoxicillin-clavulanate potassium;ciprofloxacin
10 Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain Unknown status NCT01316744 Phase 3 ketamine hydrochloride
11 Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma Unknown status NCT00052936 Phase 3 CHOP regimen;cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
12 Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia Unknown status NCT00020865 Phase 3 cefepime hydrochloride;levofloxacin
13 Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma Unknown status NCT00003815 Phase 3 carmustine;cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;melphalan;prednisolone;vincristine sulfate
14 Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma Unknown status NCT00003338 Phase 2, Phase 3
15 Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma Unknown status NCT00003337 Phase 3
16 Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma Unknown status NCT00028717 Phase 3 cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
17 Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome Unknown status NCT00002989 Phase 3 busulfan;cyclophosphamide;idarubicin;melphalan
18 Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma Unknown status NCT00003423 Phase 3 asparaginase;cyclophosphamide;cytarabine;daunorubicin hydrochloride;dexamethasone;etoposide;mercaptopurine;methotrexate;prednisolone;thioguanine;vincristine sulfate
19 Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma Unknown status NCT00053768 Phase 3 EPOCH regimen;cyclophosphamide;doxorubicin hydrochloride;etoposide;prednisone;vincristine sulfate
20 High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma Unknown status NCT00003578 Phase 3 CHOP regimen;carmustine;cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;melphalan;prednisone;vincristine sulfate
21 Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma Unknown status NCT00003924 Phase 3
22 Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma Completed NCT00059839 Phase 3 doxorubicin hydrochloride;mercaptopurine;methotrexate;prednisone;vinblastine sulfate;vincristine sulfate
23 Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma Completed NCT00052923 Phase 3 carmustine;cyclophosphamide;etoposide
24 Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma Completed NCT00002618 Phase 3 cytarabine;doxorubicin hydrochloride;leucovorin calcium;mercaptopurine;methotrexate;prednisone;vincristine sulfate
25 Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma Completed NCT00566228 Phase 3
26 A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study) Completed NCT01578499 Phase 3 Brentuximab Vedotin;Methotrexate;Bexarotene
27 R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma Completed NCT00144755 Phase 3 Darbepoetin alfa
28 ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-cell Lymphoma and Age-adjusted IPI of 1 Completed NCT00140595 Phase 3 rituximab;doxorubicin;cyclophosphamide
29 Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma Completed NCT00012051 Phase 3 carmustine;cisplatin;cytarabine;dexamethasone;etoposide;ifosfamide;melphalan;methotrexate
30 Combination Chemotherapy With or Without Rituximab in Treating Patients With Non-Hodgkin's Lymphoma Completed NCT00064116 Phase 3 CHOP regimen
31 Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications Completed NCT00799461 Phase 3
32 Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation Completed NCT00031668 Phase 3
33 Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma Completed NCT00003595 Phase 3 CHOP regimen;cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
34 Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma Completed NCT00002649 Phase 3 cyclophosphamide;etoposide
35 Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial Completed NCT00750009 Phase 3
36 American Ginseng in Treating Patients With Fatigue Caused by Cancer Completed NCT00719563 Phase 3 American ginseng
37 Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain Completed NCT00666211 Phase 3
38 Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer Completed NCT00661999 Phase 3 sodium ferric gluconate complex in sucrose
39 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
40 Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment Completed NCT00006348 Phase 3 ondansetron
41 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
42 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma Completed NCT00003215 Phase 3 CHOP regimen;cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;leucovorin calcium;melphalan;methotrexate;methylprednisolone;mitoxantrone hydrochloride;prednisone;therapeutic hydrocortisone;vincristine sulfate
43 Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer Completed NCT00053053 Phase 3
44 St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer Completed NCT00005805 Phase 3
45 Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter Completed NCT00006083 Phase 3 Fragmin
46 Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma Completed NCT00278421 Phase 3 cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
47 Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma Completed NCT00278408 Phase 3 cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
48 Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer Completed NCT00070382 Phase 3 darbepoetin alfa;epoetin alfa
49 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
50 Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma Completed NCT00005590 Phase 3 levofloxacin

Search NIH Clinical Center for Interdigitating Dendritic Cell Sarcoma

Cochrane evidence based reviews: dendritic cell sarcoma, interdigitating

Genetic Tests for Interdigitating Dendritic Cell Sarcoma

Anatomical Context for Interdigitating Dendritic Cell Sarcoma

MalaCards organs/tissues related to Interdigitating Dendritic Cell Sarcoma:

41
Bone, Liver, B Cells, Spleen, T Cells, Bone Marrow, Myeloid

Publications for Interdigitating Dendritic Cell Sarcoma

Articles related to Interdigitating Dendritic Cell Sarcoma:

(show top 50) (show all 66)
# Title Authors Year
1
Primary jejunal interdigitating dendritic cell sarcoma. ( 29414390 )
2018
2
Interdigitating dendritic cell sarcoma: Clinicopathologic study of 8 cases with review of the literature. ( 29660568 )
2018
3
Clonally related diffuse large B-cell lymphoma and interdigitating dendritic cell sarcoma sharing MYC translocation. ( 30237263 )
2018
4
Neoplastic PD-L1 expression on interdigitating dendritic cell sarcoma: A supplementary study of a case report. ( 30094900 )
2018
5
A case of interdigitating dendritic cell sarcoma studied by whole-exome sequencing. ( 30099721 )
2018
6
Interdigitating dendritic cell sarcoma located in the groin: a case report and literature review. ( 30222020 )
2018
7
A Rare Case of Interdigitating Dendritic Cell Sarcoma of the Rectum: Review of Histopathology and Management Strategy. ( 28784918 )
2017
8
An unusual case of metachronous NK/T cell lymphoma and interdigitating dendritic cell sarcoma. ( 29043241 )
2017
9
Diffuse lesion and necrosis tied to poorer prognosis of interdigitating dendritic cell sarcoma: cases report and a pooled analysis. ( 28386111 )
2017
10
Interdigitating dendritic cell sarcoma successfully treated with ABVD therapy in which serum CEA levels correlated with disease activity. ( 28484155 )
2017
11
Interdigitating dendritic cell sarcoma: diagnostic pitfalls, treatment challenges and role of transdifferentation in pathogenesis. ( 28830690 )
2017
12
Interdigitating dendritic cell sarcoma presenting in the sigmoid colon mesentery: A case report and literature review. ( 28422825 )
2017
13
Primary cutaneous interdigitating dendritic cell sarcoma is a morphologic and phenotypic simulator of poorly differentiated metastatic melanoma: A report of 2 cases and review of the literature. ( 28302385 )
2017
14
Primary Cutaneous Interdigitating Dendritic Cell Sarcoma: A Case Report and Review of the Literature. ( 27442049 )
2016
15
Oncogene Status of an Interdigitating Dendritic Cell Sarcoma: Recurrent Mutations in NF1, TP53, and ARID2 Shared With Melanoma. ( 27680605 )
2016
16
Spindle Cell Melanoma and Interdigitating Dendritic Cell Sarcoma: Do They Represent the Same Process? ( 27299798 )
2016
17
Braf mutation in interdigitating dendritic cell sarcoma: a case report and review of the literature. ( 26047060 )
2015
18
Complete Remission in Systemic Skin Interdigitating Dendritic Cell Sarcoma after ABVD Chemotherapy. ( 26106005 )
2015
19
Challenges in the differential diagnosis of interdigitating dendritic cell sarcoma of intraparotid lymph node vs. metastatic malignant melanoma with unknown primary site. ( 25722315 )
2015
20
Interdigitating dendritic cell sarcoma. ( 25691604 )
2015
21
Head and Neck Extranodal Interdigitating Dendritic Cell Sarcoma: Case Report and Review of the Literature. ( 25893828 )
2015
22
Sustained remission after ABVD treatment for interdigitating dendritic cell sarcoma. ( 26199576 )
2015
23
Intracranial Interdigitating Dendritic Cell Sarcoma: First Case Report. ( 26237342 )
2015
24
Evidence of BRAF V600E in indeterminate cell tumor and interdigitating dendritic cell sarcoma. ( 25787243 )
2015
25
Interdigitating dendritic cell sarcoma presenting in the kidney combined with retroperitoneal leiomyosarcoma: A case report and literature review. ( 24396471 )
2014
26
Interdigitating dendritic cell sarcoma presenting in the skin: diagnosis and the role of surgical resection, chemotherapy and radiotherapy in management. ( 25568750 )
2014
27
Primary Cutaneous Interdigitating Dendritic Cell Sarcoma: A Case Report and Review of the Literature. ( 25321088 )
2014
28
The genetics of interdigitating dendritic cell sarcoma share some changes with Langerhans cell histiocytosis in select cases. ( 24321462 )
2014
29
A rare case of interdigitating dendritic cell sarcoma in the nasal cavity. ( 23710400 )
2013
30
A case of interdigitating dendritic cell sarcoma/histiocytic sarcoma - a diagnostic pitfall. ( 24427360 )
2013
31
Interdigitating dendritic cell sarcoma presenting simultaneously with acute myelomonocytic leukemia: report of a rare case and literature review. ( 23605368 )
2013
32
Interdigitating dendritic cell sarcoma and follicular dendritic cell sarcoma : histopathological findings for differential diagnosis. ( 24369219 )
2013
33
Interdigitating dendritic cell sarcoma complicated with paraneoplastic pemphigus after surgery of resection. ( 23652075 )
2013
34
Interdigitating dendritic cell sarcoma presenting in the nasal region. ( 22554504 )
2012
35
Interdigitating dendritic cell sarcoma of the liver and lung: a case report with morphohological and immunohistochemical features of tumor. ( 22938549 )
2012
36
Interdigitating dendritic cell sarcoma occured alone in axilla. ( 22563543 )
2012
37
Successful treatment of disseminated interdigitating dendritic cell sarcoma with adriamycin, bleomycin, vinblastine, and dacarbazine chemotherapy. ( 22783364 )
2012
38
Small intestine perforation due to metastatic uterine cervix interdigitating dendritic cell sarcoma: a rare manifestation of a rare disease. ( 22355501 )
2011
39
Extranodal interdigitating dendritic cell sarcoma presenting in the pleura: a case report. ( 21286027 )
2011
40
Interdigitating dendritic cell sarcoma following adult liver transplantation: case report and literature review. ( 21052884 )
2011
41
Interdigitating dendritic cell sarcoma of lymph node mimicking granuloma: a case report and review of the literature. ( 22246915 )
2011
42
Narrow-band imaging of interdigitating dendritic cell sarcoma originating in the duodenum. ( 21425001 )
2011
43
Interdigitating dendritic cell sarcoma: case report with review of the literature. ( 22104162 )
2011
44
Interdigitating dendritic cell sarcoma of the ileum recurred in multiple lymph nodes and duodenum three years after operation without chemotherapy. ( 20399026 )
2010
45
Interdigitating dendritic cell sarcoma involving bone marrow in a liver transplant recipient. ( 20620556 )
2010
46
BCL2 chromosomal translocation is not a general feature of the interdigitating dendritic cell sarcoma. ( 20736747 )
2010
47
Interdigitating dendritic cell sarcoma of the tonsil. ( 20887493 )
2010
48
Molecular characterization of interdigitating dendritic cell sarcoma. ( 21139965 )
2010
49
Metastatic interdigitating dendritic cell sarcoma masquerading as a skin primary tumor: a case report and review of the literature. ( 19155734 )
2009
50
Transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma to interdigitating dendritic cell sarcoma: evidence for transdifferentiation of the lymphoma clone. ( 19926586 )
2009

Variations for Interdigitating Dendritic Cell Sarcoma

Expression for Interdigitating Dendritic Cell Sarcoma

Search GEO for disease gene expression data for Interdigitating Dendritic Cell Sarcoma.

Pathways for Interdigitating Dendritic Cell Sarcoma

GO Terms for Interdigitating Dendritic Cell Sarcoma

Cellular components related to Interdigitating Dendritic Cell Sarcoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 secretory granule membrane GO:0030667 8.62 CR1 PTPRC

Biological processes related to Interdigitating Dendritic Cell Sarcoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 regulation of complement activation GO:0030449 9.32 CR1 CR2
2 viral entry into host cell GO:0046718 9.26 CR1 CR2
3 B cell differentiation GO:0030183 9.16 CR2 PTPRC
4 B cell proliferation GO:0042100 8.96 CR2 PTPRC
5 complement receptor mediated signaling pathway GO:0002430 8.62 CR1 CR2

Molecular functions related to Interdigitating Dendritic Cell Sarcoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 virus receptor activity GO:0001618 8.62 CR1 CR2

Sources for Interdigitating Dendritic Cell Sarcoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....